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Summary.-One hundred and nineteen specimens of human mammary tissue taken
from 112 individuals, were inspected by pulsed proton magnetic-resonance tech-
niques (at 22-5 MHz). The purpose ofthe study was to evaluatethediagnosticcapabili-
ties of the nuclear magnetic resonance (NMR) technique with regard to the recogni-
tion of malignancy. The combination of two NMR parameters (spin lattice (T1) and
spin-spin(T2) relaxation times) into a malignancy index produced better than 950o/
discrimination between the 2 populations of tissue on a case-by-case basis. The mean
and standard deviations obtained were2-002±0-351 for normal tissue, and3 137±0 667
for malignant specimens. The probability that this difference is not significant is
considerably less than 0-01. In addition, specimens of fibrocystic disease and fibrous
mastopathy had indices of 2.263±0-503 and 2 151±0-505 respectively. Both groups
yielded P values less than 0-01 when compared to the malignant specimens.
A NUMBER ofprevious nuclear magnetic-
resonance (NMR) investigations of hu-
man mammary tissues have been pub-
lished (Damadian et al., 1973; Schmidt
et al., 1973; Eggleston et al., 1975; Medina
et al., 1975; Ranade et al., 1976; Beall
et al., 1976). All these studies except that
of Medina et al. (1975) were limited, in
the respect that the spin-lattice relaxation
time (T1) was the only NMR parameter
determined.
The purpose of this study was 2-fold.
First, we wished to measure NMR para-
meters other than T1, with the aim of
combining them for diagnostic purposes
into a malignancy index which could more
reliably discriminate normal tissue from
malignant tissue. Second, we wished to ex-
tend our earlier results at 100 MHz
(Damadian et al., 1973) to a larger sample
population, in order to define the confi-
dence limits ofthe technique for diagnosis.
MATERIALS AND METHODS
Autopsy material was obtained from the
morgue at the Kings County Medical Exami-
ner's Office. Samples were taken within 24 h
ofdeath, primarily from individuals who died
from accidents. The other tissue specimens
weremainlyobtainedatthesurgicalpathology
laboratory of Sloan-Kettering Memorial Hos-
pital, within hours of surgery. A small num-
ber of samples (10%) was also obtained
from the surgical pathology sections at
Methodist Hospital, as well as the State Uni-
versity Hospital at this institution. This study
included a total of 119 samples of human
mammary tissue taken from 112 different
individuals. The pathologists who supplied
thespecimens didnothave adefinitive diagno-
sis at the time we obtained them. In the
majority of cases, the technician doing the
NMR analysis did not even know the organ
from which a particular sample originated,
so that this investigation was essentially
double-blind in character.
Upon receipt ofthe specimens, a technician
would place them in an airtight test tube on
ice, and bring them to this laboratory. At
this laboratory, a second technician would
prepare a portion of the specimen for NMR
analysis and, after trimming it of fat and
connective tissue, place it in a 5 mm NMR
tube, so that it formed a column 4 mm high
after being gently tamped down. The NMRM. GOLDSMITH, J. A. KOUTCHER AND R. DAMADIAN
tubes used had both ends open in order to
make the removal of tissue for microscopic
analysis easier. The top of the NMR tube
was capped, and the bottom was sealed with a
friction-fitting Teflon plug, before the sample
was run in the NMR. Occasionally, tissue ad-
jacent to that used for the NMR analysis was
apportioned for chemical analysis. Wherever
possible, all 4 NMR parameters were deter-
mined on each sample, although time limita-
tions would occasionally force the elimination
ofaparticularmeasurement. Similarly, where-
ever possible, we restricted chemical analysis
to tissues which had also undergone NMR
investigation.
When the NMR analysis had been com-
pleted, the sample was removed from the
NMR tube and placed in a tissue cassette in a
bath of 10% formalin. At the end ofthe work
day, the tissue cassettes were brought to the
pathologylaboratoryatthisinstitution, where
the samples were prepared for microscopic
analysis. Simultaneously, the raw data from
the NMR analysis were given to a third
technician. In about 70% ofthe cases studied,
the 3 technicians referred to were 3 different
individuals. In about 20% of the cases, a
single individual had all 3 roles. This 20% of
the studywasnot "double blind" in character,
and has been considered separately under the
label ofan "intensive study" (Koutcher et al.,
1977). This individual then graphed the data,
calculated the various NMR parameters and
recorded the final values in a hardbound note-
book. A similar procedure was followed with
the chemical data when it became available.
The microscope slides prepared for each
sample were given to a pathologist for his
diagnosis. Originally, 5 slides were prepared
from each tissue block, but this was later
reduced to a single slide, to reduce unneces-
sary replication of labour. The pathologist's
report became available about one month
after the NMR analysis. At this time, the
final patient diagnosis was also available
from the hospital where the tissue originated.
As the final data reduction for the study
took place, we felt a need for a more detailed
histological description of each sample run
in the NMR. A second pathologist was re-
quested to give his diagnosis for each slide,
as well as an estimation of the percentage of
the microscopic field that contained fat, fib-
rous tissue, or normal parenchyma as well as
that percentage of the sample which was
composed ofmalignant cells. Thus, 2 separate
diagnoses from 2 different pathologists were
available for most samples.
The methods used in the NMR measure-
ments themselves and in the chemical ana-
lyses were identical to the methods described
in detail elsewhere (Goldsmith et at., 1977a;
1978).
RESULTS
In addition to normal breast tissue
obtained at autopsy, and malignant
tumours obtained at surgery, we examined
a large number of specimens (obtained at
surgery) which were classified as fibrous
mastopathy or fibrocystic disease. In all
cases, these benign conditions were co-
incident with malignancy.
Unlike most other human tissues, vir-
tually all specimens of mammary tissue
exhibit a clear 2-fraction behaviour in
their T1 plots. The proportion of fast-
relaxing material could be related to the
amount of fat seen microscopically in the
specimen slides, although the occasional
presence of large quantities of fibrous
tissue complicate this relation. These
findings are consistent with the results of
Hazlewood et al. (1972) who observed the
presence of a lipid peak in the high-
resolution spectra of protons in murine
mammary tissue. Under these conditions,
the null T1 measurement will merely repre-
sent the weighted average value for the T1
ofthe various relaxing fractions. However,
deconvolution of the complete biphasic T1
decay curve may be done by fitting the
data to a sum of 2 exponentials in a non-
linear regression analysis. Such computer
analyses were done on all breast samples
and allowed us to compute a separate T1
value for the slow-relaxing fraction alone
(Tl). The results ofthis Tl determination
are indicated in Fig. 1. The upper level of
the graph indicates the distribution of
values for normal and malignant speci-
mens. The lower level of the graph indi-
cates the distribution for samples exhibit-
ing fibrous mastopathy or fibrocystic
disease. Fig. 2 gives a similar plot for the
parameter T2 (spin-spin relaxation time).
All these results are plotted as histograms
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FIG. 1.-T1 distribution of the slow-relaxing fraction of human mammary tissues. UJpper level:
normal and malignant specimens. Lower level: Specimens of fibrous mastopathy and fibrocystic
disease from cancer patients.
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FiG. 2. T2 distribution of human mammary tissues. Upper level: normal and malignant specimens.
Lower level: specimens of fibrous mastopathy and fibrocystic disease from cancer patients.550 M. GOLDSMITH, J. A. KOUTCHER AND R. DAMADIAN
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FIG. 3.-Distribution of the malignancy index of human mammary tissues. -Upper level: normal and
malignant tissues. Lower level: specimens of fibrous mastopathy and fibrocystic disease from
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FIG. 4.-Comparison of the results of null T1 measurements on human mammary tissues. Upper
level: this study. Lower level: Eggleston et al. (1975).
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to enable the reader to determine whether
the mean values are truly representative
of the group. The results represent
measurements made by 4 different indivi-
duals over a period of 2 years. It is clear
from the distributions indicated that T2
gives the best discrimination. Since some
degree of overlap is evident even in the
case of this parameter, we hoped that a
combined malignancy index would be
more reliable than any single parameter,
in discriminating normal from malignant
specimens. We decided to try a "normal-
ized sum" of the relaxation constants T1l
and T2, because the former is generally
10 x the latter. T,p was not included in
the index because its addition did not
increase the separation of the groups,
although it did not decrease the separation
obtained with T1l and T2 alone. Thus,
following "separation algorithm":
Malignancy Index
(Tls)i (T2)i
(Ti8)normal (T2)normal
where (T18)i, and (T2)i are Tj, and T2 of
the ith specimen, and (T18) normal, and
(T2) normal are the mean values of T1l
and T2 for the normal population.
Fig. 3 shows the distribution in the
malignancy index for the samples in Figs.
1 and 2. Note that there is very little
overlap between the 2 groups. Indeed,
7500 of the cancer samples fall outside 2
standard deviations from the mean of the
normal population. Furthermore, if an
index of 2-300 is used as the cut-off
between the 2 populations, only one
cancer and one normal specimen fall on
the wrong side of the cut-off value. Thus,
the use of the Malignancy Index (defined
in equation (1)) allows better than 95%
separation between the normal and malig-
nant populations on a case-by-case basis.
The numerical analysis ofthe data in these
histograms, as well as the T1p results, is
presented in Table I.
DISCUSSION
The results of this study are in general
agreement with the results ofMedina et al.
(1975) who found that T2 was more dis-
criminating than T1 for human breast
tissue, and that discrimination between
non-neoplastic tissue and carcinomas
could be made with 850% confidence. A
direct numerical comparison of T1 and T2
values cannot be made, however, since the
measurements of this group were made at
a frequency of 30 3 MHz. On the other
hand, theMalignancy Index isafrequency-
independent quantity (except where the
relaxation times of normal and malignant
tissues show a difference in frequency
dependence) by which comparisons can
be made when both T1 and T2 data are
available.
We have calculated the Malignancy
Index for each of the samples presented
TABLE I. Summary ofNMIR results at 22-5 MHz on human breast specimens
(relaxation times3 in second8)
Maligna T1 null T1s T2 Tip inde
Meain 0 447 0 554 0 046 0 114 2-0(
Normal s.d. 0 - 136 0-112 0 014 0 -031 0 3¢
N 12 11 11 7 11
Mean 0 452 0 630 0 092 0- 124 3 -1'
Cancer s.d. 0- 147 0- 189 0-021 0 036 0 6(
N 26 27 25 21 25
Fibrous Mean 0 356 0 577 0 051 0 094 2-1l
mastopathy s.d. 0 - 106 0 - 123 0-019 0 029 0 5(
N 65 64 55 61 55
Fibrocystic Mean 0 374 0 556 0 058 0 102 2 -2(
disease s.d. 0-104 0- 130 0 022 0 029 0 5(.
ancy
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TABLE II.-Calcaylation of the malignancy indexfrom the data on human breast samples of
Medina et al. (1975). All values in milliseconds.
Normal
-
T1 T2 Index
550 26 -5 1-553
614 29 0 1-717
701 26 - 3 1 - 769
643 32-6 1-861
736 42 0 2-262
810 41-4 2-354
719 50*6 2-480
682 35-5 1-999
85 9 3 0-360
7 7 7
Mean
s.d.
N
Adenocarcinoma
Ti T2 Index
666 62-5 2-737
753 60 0 2-794
748 61-3 2 - 824
809 62-1 2-936
804 63-4 2-965
999 56-3 3 -051
939 60-3 3 075
849 65-6 3 093
930 62-0 3-110
816 7-12 3-202
987 63-2 3-228
805 77-6 3*366
822 81 8 3 -510
964 74-8 3-521
961 75-4 3 -533
881 85-6 3 703
1120 83-7 4 000
874 68 -6 3 -215
116 9 5 0 347
17 17 17
Fibrocystic
T1 T2 Index
576 15-3 1 -276
457 30-2 1-521
546 26 -3 1 -541
598 24 -3 1 -561
648 24-7 1-646
610 27 - 3 1 -663
601 29-7 1-718
696 29-4 1-849
576 36-6 1-876
756 27-3 1-878
690 34-4 1 -981
677 35-6 1-996
630 38-5 2-008
625 38-9 2-012
681 36-6 2 030
613 46 0 2-195
792 40 9 2-313
728 45 0 2-335
697 49-3 2-411
697 60 0 2-712
936 82-7 3-702
655 37 0 2-011
96 13-8 0-517
21 21 21
Fibroadenoma
Ti T2 Index
725 47-8 2-410
963 47 0 2-736
1194 36-8 2-787
891 61-0 3 -025
1008 56-1 3-058
899 66-1 3 - 180
1080 90-1 4-122
1080 94-7 4-251
980 62 -5 3 - 196
144 20-7 0 656
8 8 8
by Medina et al. (1975) and the results,
along with the original data points, are
presented in Table II. Here a cut-offvalue
of 2-500, produces 100% separation be-
tween the normal and cancer populations.
More impressively, 100% of the cancers
have indices more than 2 standard devia-
tions from the mean ofthe normal popula-
tion. Thus, our results and those ofMedina
et al. agree very well.
The results of this study may also be
directly compared to those of a smaller
study at a similar frequency (24 MHz)
(Eggleston et al., 1975). The comparison
is made in the histograms in Fig. 4. The
data in the upper portion of the figure is
that presented above; that in the lower
portion is from the paper of Eggleston et
al. (1975). It is clear that the results of
both groups with regard to the distribu-
tions of null T1 among the various cate-
gories of tissue also agree quite well.
Unfortunately, the other NMR parameters
were not determined in that study, so
that a test of the Malignancy Index with
respect to their data is not possible. From
the null T1 data in Fig. 4, Eggleston et al.
drew the conclusion that NMR is unable to
distinguish cancer from benign pathologi-
cal states. We believe that this conclusion,
as it is based only on the null T1 measure-
ments on relatively few samples, is not
justified. This is true especially in the
absence of enough data to compute a
"malignancy index". On the contrary, we
believe that our preliminary evidence
indicates that, at the very least, a signifi-
cant proportion ofbenign pathologies may
be distinguished from malignancy by
NTMR techniques.
To clarify this point further, we note
that the use of the Malignancy Index
yields P values (the probability that the
difference between means arises by chance)
less than 0X01 for either category of
benign pathology given in Table I when
they are compared to the cancer group.
This is true despite the fact that these
benign pathologies came from patients
with cancer, a situation which might give
high values to histologically normal tissue
(Frey et al., 1972; Koutcher et al., 1977;
Goldsmith et al., 1978; Fruchter et al.,
1978). In addition, the earlier results of
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Medina et al. (1975) demonstrated that,
although fibroadenomas could not be
immediately distinguished from cancer,
fibrocystic disease gave relaxation values
not significantly different from normal
tissue. Indeed, Table II shows that only
one of his specimens out of 21 has a
malignancy index clearly in the cancer
region. It remains to be seen whether
these overlap cases can be correlated with
premalignant conditions, or if indeed a
more careful study of benign pathologies
might relate them to the fact that the
patients involved also hosted a nearby
malignancy.
Part of the pessimism of the Eggleston
group stems from theinclination to assume
that superficially "wet" benign states,
such as inflammation, will interfere with
the cancer-diagnostic abilities of NMR.
This is shown by the statement (Eggleston
et al., 1975) "that prolongation of the
spin-lattice relaxation time is largely the
result of increased water content of the
tissue examined . . .". However, this
group offered no experimental measure-
ments on the tissues they studied to
support this conclusion.
Indeed, we find the relationship between
the tissue relaxation times and the tissue
water content to be as yet unclear. For
example, we were able to relate these 2
variables in colon specimens (Goldsmith
et al., 1978) and they did not show a
relationship in lung specimens (Goldsmith
et al., 1977a).
Breast tissue (and adipose tissue, which
is present in breast specimens to varying
degrees) presents a clear demonstration
that factors other than water content
TABLE III.-Comparison of chemical and
NMR characteristics of human adipose
and breast tissue
Water/dry
T1 null T2 weight
(seconds) (seconds) (grams)
Adipose Mean 0* 133 0* 105 0*208
tissue s.d. 0*019 0*016 0* 105
N 36 32 13
Normal Mean 0*447 0*046 2 -956
breast s.d. 0*136 0-014 0 -961
tissue N 11 11 10
affect the relaxation times of biological
specimens. Table III is a briefsummary of
measurements we made on adipose tissue
taken from female breast specimens and
on lobular breast specimens dissected
free of fat. The adipose tissue (top row)
has one order of magnitude less water
than the breast tissue (bottom row);
however, the relative changes in T1 and
T2 values are in opposite directions. In
general, we have consistently found that
the presence of fat in a sample lowers T1,
but raises T2. Thus, the dependence of the
relaxation times T1 and T2 in these tissues
are hardly predictable from water content
alone. Especially in breast tissue, with its
highly variable fat content, these results
demand more than a priori assumptions
about the effects of water on samiple
relaxation times.
Certainly, the ability of NMR to dis-
tinguish benign pathology from cancer
does require further investigation, with
special care taken to obtain specimens
from cancer-free patients. Therecent NMR
imaging of the live human chest (Dama-
dian et al., 1977; Minkoffet al., 1977; Gold-
smith et al., 1977b) gives some hope that
these questions can be answered by
application of in vivo NMR methodology.
In any case, we believe that the benign vs
malignant question is the next appro-
priate problem, in that the results of the
present investigation firmly demonstrate
that a clear distinction can be made
between normal and malignant specimens.
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